MedTrace Logo

Reinfection After Eradication of Helicobacter Pylori Infection

NCT02674802 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2016-02-04

No results posted yet for this study

Summary

Helicobacter pylori is closely related with gastritis, peptic ulcer, gastric cancer and gastric MALT lymphoma, and it may participate in a variety of parenteral diseases. Infection rates of Helicobacter pylori is still high, so effectively eradication is necessary. At present, the eradication therapy has achieved very good curative effect. However, relapse after eradication is unoptimistic. This study has made an analysis for reinfection after eradication of Helicobacter pylori Infection include the retrospective and prospective studies, aims to explore the epidemiological data and related risk factors of Hp reinfection in China.

Conditions

  • Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
  • Eradication Therapy of Helicobacter Pylori
  • Detection of Helicobacter Pylori

Sponsors & Collaborators

  • The First Affiliated Hospital of Nanchang University

    lead OTHER

Principal Investigators

  • Nonghua Lv, MD · The First Affiliated Hospital of Nanchang University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-03-31
Completion
2016-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02674802 on ClinicalTrials.gov